Evidence map›Paper›PMID 42243945›Full record

Observational studyBMC health services research2026

Costs of autism spectrum disorders and access to services in Spain.

Lidia García-Pérez, Vanesa Ramos-García, Renata Linertová, Cristina Valcárcel-Nazco, Beatriz Santos, Ricardo Canal-Bedia, Valentina Iemmi, Martin Knapp, Maria Luisa Scattoni, Diana Schendel and 2 more

Abstract readObservational Study
In one paragraph

Observational study in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lidia García-PérezEvaluation Unit of the Canary Islands Health Service (SESCS), Santa Cruz de Tenerife, Spain. lidia.garciaperez@sescs.es.ORCID http://orcid.org/0000-0002-5626-8116
Vanesa Ramos-GarcíaEvaluation Unit of the Canary Islands Health Service (SESCS), Santa Cruz de Tenerife, Spain.ORCID http://orcid.org/0000-0002-9106-2420
Renata LinertováEvaluation Unit of the Canary Islands Health Service (SESCS), Santa Cruz de Tenerife, Spain.ORCID http://orcid.org/0000-0002-0138-9252
Cristina Valcárcel-NazcoEvaluation Unit of the Canary Islands Health Service (SESCS), Santa Cruz de Tenerife, Spain.ORCID http://orcid.org/0000-0003-4833-7967
Beatriz SantosCanary Islands Health Research Institute Foundation (FIISC), Santa Cruz de Tenerife, Spain.
Ricardo Canal-BediaInstituto Universitario de Integración en la Comunidad, University of Salamanca, Dpto. Personalidad, Evaluación y Tratamiento Psicológicos, Salamanca, Spain.ORCID http://orcid.org/0000-0003-0247-0295
Valentina IemmiSchool of Health and Social Care, University of Essex, Colchester, UK.ORCID http://orcid.org/0000-0003-3301-0689
Martin KnappDepartment of Health Policy, London School of Economics and Political Science, London, UK.ORCID http://orcid.org/0000-0003-1427-0215
Maria Luisa ScattoniResearch Coordination and Support Service, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-6659-0280
Diana SchendelAarhus University, National Centre for Register-Based Research, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-8588-1227
Manuel PosadaRare Diseases Research Institute, Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-8372-4180
Pedro Serrano-AguilarEvaluation Unit of the Canary Islands Health Service (SESCS), Santa Cruz de Tenerife, Spain.ORCID http://orcid.org/0000-0002-5373-410X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition with significant impact on families and society. The objective of this article is to present the results of the first cost-of-illness study of ASD in Spain.

methodsAn observational, cross-sectional study was designed to estimate the annual cost per individual by means of an anonymous survey and a bottom-up approach to collect use of services and costs. A societal perspective was adopted, including direct costs related to education, health care, and social care sectors, and productivity loss.

resultsComplete responses of 334 individuals on the spectrum were obtained (mean age 12.3 years, 82% male, 46.4% with autistic disorder). The most used health care services were general practitioners (35.6%), accident and emergency services (15.3%), and community nurses (10.8%). Among specialized health care services, the most frequently used were psychologists, psychiatrists and other types of individual therapy. The most used drugs were antipsychotics. There was a variety of social services available and accessed. The most often reported service accessed by carers was additional visits to general practitioner (15%). The average annual direct cost of ASD in Spain was €10,974 per individual (95%CI 8717-13879). Logistic regression found that individuals with anxiety, intellectual disability, and an autistic disorder were more likely to access services. The average cost of productivity losses per carer was €2186.4.

conclusionsThe average annual direct cost of ASD in Spain was €10,974 per individual. Individuals with anxiety or intellectual disability co-occurring with autistic disorder were more likely to access services. Findings from this study would be useful to inform service planning and future research.

Indexed as

Autism Spectrum DisorderHealth Services AccessibilityAdolescentChildChild, PreschoolCost of IllnessCross-Sectional StudiesFemaleHealth Care CostsHumansMaleSpainAsperger’s disorderAutism spectrum disorderAutistic disorderCost-of-illness studyEconomic analysisSpainUse of services

Identifiers

PMID42243945
PMCPMC13459201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.